Commonwealth Equity Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$414M Buy
344,848
+41,553
+14% +$42.5M 0.52% 25
2026
Q1
$279M Sell
303,295
-11,091
-4% -$11.2M 0.39% 45
2025
Q4
$338M Sell
314,386
-38,758
-11% -$37.1M 0.45% 34
2025
Q3
$269M Sell
353,144
-18,358
-5% -$13.7M 0.35% 46
2025
Q2
$290M Sell
371,502
-5,718
-2% -$4.44M 0.38% 43
2025
Q1
$312M Buy
377,220
+17,344
+5% +$14.4M 0.44% 38
2024
Q4
$278M Sell
359,876
-6,368
-2% -$5.27M 0.41% 43
2024
Q3
$324M Sell
366,244
-3,678
-1% -$3.31M 0.49% 30
2024
Q2
$335M Buy
369,922
+6,621
+2% +$5.3M 0.53% 25
2024
Q1
$283M Buy
363,301
+8,736
+2% +$6.22M 0.47% 31
2023
Q4
$207M Buy
354,565
+17,461
+5% +$10.2M 0.38% 43
2023
Q3
$181M Buy
337,104
+7,254
+2% +$3.74M 0.38% 44
2023
Q2
$155M Buy
329,850
+319
+0.1% +$134K 0.31% 58
2023
Q1
$113K Sell
329,531
-16,088
-5% -$5.43M 0.24% 79
2022
Q4
$126M Sell
345,619
-4,648
-1% -$1.65M 0.3% 64
2022
Q3
$113M Sell
350,267
-788
-0.2% -$250K 0.29% 68
2022
Q2
$114M Buy
351,055
+16,589
+5% +$4.98M 0.3% 66
2022
Q1
$95.8M Buy
334,466
+2,889
+0.9% +$744K 0.22% 89
2021
Q4
$91.6M Buy
331,577
+7,575
+2% +$1.92M 0.21% 95
2021
Q3
$74.9M Buy
324,002
+292
+0.1% +$72.1K 0.19% 110
2021
Q2
$74.3M Buy
323,710
+31,009
+11% +$6.23M 0.19% 110
2021
Q1
$54.7M Buy
292,701
+18,148
+7% +$3.55M 0.15% 138
2020
Q4
$46.4M Sell
274,553
-4,238
-2% -$633K 0.14% 154
2020
Q3
$41.3M Buy
278,791
+32,997
+13% +$5.11M 0.14% 154
2020
Q2
$40.4M Buy
245,794
+6,063
+3% +$931K 0.15% 141
2020
Q1
$33.3M Sell
239,731
-611
-0.3% -$84K 0.15% 132
2019
Q4
$31.6M Buy
240,342
+8,439
+4% +$978K 0.12% 168
2019
Q3
$25.9M Buy
231,903
+241
+0.1% +$26.8K 0.11% 181
2019
Q2
$25.7M Buy
231,662
+4,749
+2% +$559K 0.11% 183
2019
Q1
$29.4M Buy
226,913
+23,501
+12% +$2.86M 0.14% 154
2018
Q4
$23.5M Buy
203,412
+2,096
+1% +$234K 0.13% 159
2018
Q3
$21.6M Sell
201,316
-3,185
-2% -$318K 0.1% 188
2018
Q2
$17.4M Buy
204,501
+643
+0.3% +$52.8K 0.09% 212
2018
Q1
$15.8M Sell
203,858
-4,334
-2% -$349K 0.09% 214
2017
Q4
$17.6M Buy
208,192
+1,869
+0.9% +$159K 0.1% 192
2017
Q3
$17.6M Buy
206,323
+3,069
+2% +$252K 0.11% 183
2017
Q2
$16.7M Sell
203,254
-18,127
-8% -$1.48M 0.11% 182
2017
Q1
$18.6M Buy
221,381
+5,347
+2% +$428K 0.12% 158
2016
Q4
$15.9M Buy
216,034
+13,492
+7% +$1M 0.12% 177
2016
Q3
$16.3M Sell
202,542
-7,486
-4% -$599K 0.13% 164
2016
Q2
$16.5M Buy
210,028
+5,736
+3% +$432K 0.14% 152
2016
Q1
$14.7M Sell
204,292
-2,973
-1% -$225K 0.13% 159
2015
Q4
$17.5M Buy
207,265
+21,952
+12% +$1.82M 0.17% 135
2015
Q3
$15.5M Buy
185,313
+24,223
+15% +$2.04M 0.16% 134
2015
Q2
$13.4M Buy
161,090
+2,875
+2% +$219K 0.13% 155
2015
Q1
$11.5M Buy
158,215
+4,378
+3% +$312K 0.12% 178
2014
Q4
$10.6M Sell
153,837
-959
-0.6% -$64.7K 0.12% 168
2014
Q3
$10M Buy
154,796
+10,121
+7% +$641K 0.12% 161
2014
Q2
$8.99M Buy
144,675
+681
+0.5% +$40.6K 0.11% 179
2014
Q1
$8.47M Sell
143,994
-19,715
-12% -$1.1M 0.12% 175
2013
Q4
$8.35M Sell
163,709
-3,197
-2% -$160K 0.12% 161
2013
Q3
$8.4M Buy
166,906
+11,825
+8% +$619K 0.14% 150
2013
Q2
$7.62M Buy
+155,081
New +$8.44M 0.13% 152

Other funds holding LLY

Commonwealth Equity Services's LLY Position: Q2 2026 in Review

Commonwealth Equity Services increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $42.5M and bringing the position to 344,848 shares worth $414M. The position accounts for 0.52% of the portfolio, ranked #25.

Commonwealth Equity Services first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Commonwealth Equity Services held 344,848 shares of Eli Lilly worth $414M as of Q2 2026.
  • Commonwealth Equity Services bought 41,553 Eli Lilly shares in Q2 2026, an estimated $42.5M.
  • Eli Lilly made up 0.52% of Commonwealth Equity Services's portfolio in Q2 2026, its #25 holding.
  • Commonwealth Equity Services first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.